Zhitong Finance App News, Jinxin Reproduction (01951.HK) issued an announcement. Relying on its existing clinical and reproductive medicine capabilities, the Group plans to further develop a translational medicine platform focusing on women's health. The platform will combine the Group's existing innovation center, genetic testing center, subsidiary research platform, clinical network and reproductive medicine expertise to promote the transformation of research results into clinical application.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.